Concepedia
Statistics
Publications
4
Citations
276
H-Index
Active since
2011
Affiliations
Robert Bosch Hospital(Current)
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology
Weizmann Institute of Science
Andrea Weilbacher is an author at Robert Bosch Hospital specializing in oncology, apoptosis, and molecular oncology.
Publications per year
2011–2014
p53 Hypersensitivity Is the Predominant Mechanism of the Unique Responsiveness of Testicular Germ Cell Tumor (TGCT) Cells to Cisplatin
Matthias Gutekunst, Moshe Oren, Andrea Weilbacher et al. · PLoS ONE · 2011 · 96 citations · Full text
Medicine, Molecular Biology, Oncology +17
RITA can induce cell death in p53-defective cells independently of p53 function via activation of JNK/SAPK and p38
Andrea Weilbacher, Matthias Gutekunst, Moshe Oren et al. · Cell Death and Disease · 2014 · 61 citations · Full text
Medicine, Cancer Biology, Oncology +17
Cisplatin Hypersensitivity of Testicular Germ Cell Tumors Is Determined by High Constitutive Noxa Levels Mediated by Oct-4
Matthias Gutekunst, Thomas Mueller, Andrea Weilbacher et al. · Cancer Research · 2013 · 60 citations
Medicine, Molecular Biology, Oncology +14
Discrepant NOXA (PMAIP1) transcript and NOXA protein levels: a potential Achilles’ heel in mantle cell lymphoma
Michael A. Dengler, Andrea Weilbacher, Matthias Gutekunst et al. · Cell Death and Disease · 2014 · 59 citations · Full text
Life Sciences, Molecular Biology, Oncology +17
1–4 of 4